CONTINUOUS SUBCUTANEOUS INFUSIONS (CSCI)
- The administration of medication by continuous infusion into the subcutaneous tissue via a pump
- commonly used in palliative care to achieve symptom control
WHEN TO USE
- Use oral route as long as practical and effective
- Consider CSCI in palliative patients who require regular medication to control symptoms but are unable to take or absorb oral medications because they:
- are semi-conscious, unconscious or very fatigued
- are vomiting or nauseated
- have dysphagia
- have abdominal pathology likely to reduce absorption e.g. bowel perforation or obstruction
- are in last hours or days of life when it is anticipated patient will deteriorate and be unable to take oral medications
WHAT TO USE
Guidance
- For detailed guidance on which drugs can be given by CSCI and which drugs can be combined in a single infusion, contact the Palliative Care Team, Medicines Information or see BNF section on prescribing in palliative care
Drugs commonly administered by CSCI
Analgesics
- Morphine
- Oxycodone
- Alfentanil
Anti-emetics
- Metoclopramide
- Cyclizine
- Haloperidol
- Levomepromazine
Anxiolytics
- Midazolam
Antisecretory
- Hyoscine butylbromide
- Hyoscine hydrobromide
Drugs NOT suitable for CSCI
- Diazepam
- Antimicrobials
- Chlorpromazine
- Prochlorperazine
STARTING AND CONVERTING OPIOIDS TO CSCI
- Remember equivalent SC doses may differ from the oral dose for opioid analgesics
- If help needed contact the Palliative Care Team or Medicines Information
Patients who are not currently on opioids
- Patients who have not previously been on opioids, a suitable starting dose is morphine 5-10 mg over 24 hr
Patients already on regular opioids
- When converting from oral morphine to subcutaneous morphine a 2:1 ratio is a useful guide e.g. 2 mg oral morphine = 1 mg subcutaneous morphine
- Always add up total of the regular and breakthrough doses of morphine over a 24-hr period
Example 1
- Patient on modified release morphine (e.g. Zomorph®) 15 mg 12-hrly, total daily dose = 30 mg
- Subcutaneous morphine dose = 30 ÷ 2 = 15 mg/24 hr
Example 2
- Patient on modified release morphine (e.g. Zomorph®) 30 mg 12-hrly and has had 3 x 10 mg breakthrough doses of morphine sulphate solution in last 24 hr
- Total daily dose = 90 mg
- Subcutaneous morphine dose = 90 ÷ 2 = 45 mg/24 hr
Patients already on fentanyl patch
- If patient already on fentanyl patch and requiring CSCI:
- if pain controlled, continue fentanyl patch to maintain pain control
- if pain not controlled, refer to Palliative Care Team for advice and do not discontinue patch
HOW TO PRESCRIBE CSCI
Types of pump/driver
McKinley® T34 syringe pump
- Battery powered, portable
Alaris® GS or GH syringe pump
- Mains electricity powered, non-portable
Prescribing CSCI on prescription chart
- List of drugs to be added and doses
- e.g. Morphine 10 mg and metoclopramide 30 mg
- Diluent - unless instructed otherwise by Palliative Care Team, use water for injection
- e.g. Made up with water for injection
- Volume to be made up to, rate of administration and pump to be used
- e.g. McKinley® T34: Make up to 17 mL and infuse over 24 hr
- e.g. Alaris®: Make up to 24 mL and infuse at 1 mL/hr or Make up to 48 mL and infuse at 2 mL/hr
- Route: SC
DISCHARGING AND TRANSFERRING PATIENTS ON CSCI
- Continue infusion during transfer
- Replenish pump before transfer
- Ensure adequate supply of medication to replenish pump sent home with patient
- especially before a weekend or bank holiday
Communication
- If patient going home, ensure CSCI prescribed on district nurse authorisation document
- When booking transport, inform transport co-ordinator McKinley® T34 pump is in use
Contact receiving nurse
- Discharging home - district nurse
- Discharging to nursing home, hospice or community hospital - nurse on duty
- Instruct the receiving nurse to:
- change to a community pump on 1st visit
- return pump to hospital
- Include CSCI details in discharge letter to GP
- specify name and dose of all medications in the infusion
Date updated: 2024-02-20